| scholarly article | Q13442814 |
| P2093 | author name string | Wei Sun | |
| Jing-Tao Zhang | |||
| Yue-Zu Fan | |||
| Fang-Tao Wang | |||
| P2860 | cites work | Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis | Q64379930 |
| Anti-angiogenesis: new concept for therapy of solid tumors | Q70493357 | ||
| Tumor induction of VEGF promoter activity in stromal cells | Q77349243 | ||
| Identification of fibroblast heterogeneity in the tumor microenvironment | Q79360133 | ||
| Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas | Q81168633 | ||
| CD24 and galectin-1 expressions in gastric adenocarcinoma and clinicopathologic significance | Q83005419 | ||
| Tumor stroma reaction-related gene signature predicts clinical outcome in human hepatocellular carcinoma | Q84081961 | ||
| High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer | Q84584414 | ||
| Angiogenesis | Q84637384 | ||
| Periostin: a putative mediator involved in tumour resistance to anti-angiogenic therapy? | Q85096834 | ||
| Podoplanin expressing cancer associated fibroblasts are associated with unfavourable prognosis in adenocarcinoma of the esophagus | Q85475870 | ||
| Podoplanin in cancer cells is experimentally able to attenuate prolymphangiogenic and lymphogenous metastatic potentials of lung squamoid cancer cells | Q39638391 | ||
| Galectin-1-mediated tumor invasion and metastasis, up-regulated matrix metalloproteinase expression, and reorganized actin cytoskeletons | Q39874836 | ||
| PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment | Q39901011 | ||
| The essential role of fibroblasts in esophageal squamous cell carcinoma-induced angiogenesis | Q39987977 | ||
| Melanoma vasculogenic mimicry is strongly related to reactive oxygen species level | Q40054247 | ||
| Antitumor activities of a novel indolin-2-ketone compound, Z24: more potent inhibition on bFGF-induced angiogenesis and bcl-2 over-expressing cancer cells | Q40508501 | ||
| Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies | Q40751413 | ||
| Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression | Q40788311 | ||
| Vascular mimicry in glioblastoma following anti-angiogenic and anti-20-HETE therapies. | Q41096029 | ||
| TGFβ1 and HGF protein secretion by esophageal squamous epithelial cells and stromal fibroblasts in oesophageal carcinogenesis | Q41832195 | ||
| Aberrant glioblastoma neovascularization patterns and their correlation with DCE-MRI-derived parameters following temozolomide and bevacizumab treatment | Q42638789 | ||
| Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy | Q44164588 | ||
| Cancer-associated fibroblast and M2 macrophage markers together predict outcome in colorectal cancer patients | Q44371574 | ||
| Distinct progression-associated expression of tumor and stromal MMPs in HaCaT skin SCCs correlates with onset of invasion | Q44548511 | ||
| Stromal fibroblasts activated by tumor cells promote angiogenesis in mouse gastric cancer | Q46582619 | ||
| Treatment of advanced renal cell carcinoma with the combination bevacizumab/erlotinib/imatinib: a phase I/II trial | Q46756092 | ||
| Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer | Q47327100 | ||
| Low dosage of arsenic trioxide inhibits vasculogenic mimicry in hepatoblastoma without cell apoptosis. | Q47401268 | ||
| COE inhibits vasculogenic mimicry in hepatocellular carcinoma via suppressing Notch1 signaling | Q47940151 | ||
| Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes | Q49835603 | ||
| MicroRNA-27b functions as a new inhibitor of ovarian cancer-mediated vasculogenic mimicry through suppression of VE-cadherin expression. | Q51064283 | ||
| Contribution of the PI3K/MMPs/Ln-5γ2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas. | Q51067071 | ||
| HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation. | Q51152435 | ||
| Mesenchymal Stem Cells are Recruited and Activated into Carcinoma-Associated Fibroblasts by Prostate Cancer Microenvironment-Derived TGF-β1. | Q51703464 | ||
| Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells. | Q51772134 | ||
| The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma. | Q52141308 | ||
| Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma. | Q54333727 | ||
| Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma. | Q54599974 | ||
| Hepatic stellate cells accelerate the malignant behavior of cholangiocarcinoma cells | Q54636179 | ||
| HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro. | Q54788547 | ||
| Stromal Expression of MMP-13 Is Required for Melanoma Invasion and Metastasis | Q59591349 | ||
| Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo | Q39422046 | ||
| CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer | Q24318416 | ||
| Tumor cell vasculogenic mimicry: from controversy to therapeutic promise | Q26829921 | ||
| Rationale behind targeting fibroblast activation protein-expressing carcinoma-associated fibroblasts as a novel chemotherapeutic strategy | Q27004215 | ||
| Fibroblast activation protein α in tumor microenvironment: recent progression and implications (review) | Q28082504 | ||
| TGFβ signalling in context | Q28275410 | ||
| Breast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesis | Q28743545 | ||
| Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting | Q28755868 | ||
| Molecular mechanisms and clinical applications of angiogenesis | Q29547314 | ||
| Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion | Q29547317 | ||
| Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer | Q29547558 | ||
| The microenvironment of the tumour-host interface | Q29620375 | ||
| Vasculogenic mimicry and tumor angiogenesis | Q30498765 | ||
| Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy? | Q33209124 | ||
| Demonstrating circulation in vasculogenic mimicry patterns of uveal melanoma by confocal indocyanine green angiography | Q33278922 | ||
| PDGF-C induces maturation of blood vessels in a model of glioblastoma and attenuates the response to anti-VEGF treatment | Q33427833 | ||
| Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model | Q33517133 | ||
| Inhibition of tumor vasculogenic mimicry and prolongation of host survival in highly aggressive gallbladder cancers by norcantharidin via blocking the ephrin type a receptor 2/focal adhesion kinase/paxillin signaling pathway | Q33584252 | ||
| Relationships of alpha-SMA-positive fibroblasts and SDF-1-positive tumor cells with neoangiogenesis in nasopharyngeal carcinoma | Q33609069 | ||
| Cancer associated fibroblasts in cancer pathogenesis | Q33664004 | ||
| COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems | Q33703810 | ||
| Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry | Q33874221 | ||
| Angiomodulin, a marker of cancer vasculature, is upregulated by vascular endothelial growth factor and increases vascular permeability as a ligand of integrin αvβ3 | Q33913526 | ||
| Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion | Q33934433 | ||
| PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor | Q33945092 | ||
| MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma | Q33947759 | ||
| Development of SU5416, a selective small molecule inhibitor of VEGF receptor tyrosine kinase activity, as an anti-angiogenesis agent | Q33963448 | ||
| Angiomodulin is a specific marker of vasculature and regulates vascular endothelial growth factor-A-dependent neoangiogenesis. | Q34113868 | ||
| Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage | Q34144848 | ||
| Diversity, topographic differentiation, and positional memory in human fibroblasts | Q34190312 | ||
| Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications | Q34265783 | ||
| Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy | Q34391376 | ||
| Cancer-associated fibroblasts from hepatocellular carcinoma promote malignant cell proliferation by HGF secretion | Q34718091 | ||
| Endoglin regulates cancer-stromal cell interactions in prostate tumors | Q34988080 | ||
| Adverse effects of anticancer agents that target the VEGF pathway | Q34990961 | ||
| A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro | Q34995053 | ||
| Matrix metalloproteinase (MMP)-9 in cancer-associated fibroblasts (CAFs) is suppressed by omega-3 polyunsaturated fatty acids in vitro and in vivo | Q35107715 | ||
| Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway | Q35120530 | ||
| Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy | Q35127584 | ||
| Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma | Q35463820 | ||
| Fibroblast activation protein and its prognostic significance in correlation with vascular endothelial growth factor in pancreatic adenocarcinoma | Q35549869 | ||
| Targeting the expression of platelet-derived growth factor receptor by reactive stroma inhibits growth and metastasis of human colon carcinoma. | Q35569799 | ||
| Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations | Q35754294 | ||
| PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma | Q35811104 | ||
| Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis | Q35848075 | ||
| Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin | Q35947656 | ||
| NOTCH3 Is Induced in Cancer-Associated Fibroblasts and Promotes Angiogenesis in Oral Squamous Cell Carcinoma | Q36001853 | ||
| Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts | Q36028740 | ||
| Angiogenesis inhibitors in the treatment of cancer | Q36222054 | ||
| Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with "Warburg-like" cancer metabolism and L-lactate production. | Q36235529 | ||
| FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7 | Q36262850 | ||
| Cdc42EP3/BORG2 and Septin Network Enables Mechano-transduction and the Emergence of Cancer-Associated Fibroblasts | Q36426917 | ||
| Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression. | Q36426956 | ||
| p16INK4A represses breast stromal fibroblasts migration/invasion and their VEGF-A-dependent promotion of angiogenesis through Akt inhibition. | Q36520748 | ||
| Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma | Q36545163 | ||
| Stromal fibroblasts in cancer: a novel tumor-promoting cell type | Q36553020 | ||
| Targeting of cancer‑associated fibroblasts enhances the efficacy of cancer chemotherapy by regulating the tumor microenvironment | Q36624058 | ||
| Antiangiogenesis and vascular endothelial growth factor/vascular endothelial growth factor receptor targeting as part of a combined-modality approach to the treatment of cancer | Q36937491 | ||
| Molecular targets on blood vessels for cancer therapies in clinical trials | Q37032236 | ||
| Tumor vasculature and microenvironment normalization: a possible mechanism of antiangiogenesis therapy | Q37318120 | ||
| Combination of antiangiogenesis with chemotherapy for more effective cancer treatment | Q37346912 | ||
| The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. | Q37448181 | ||
| Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice | Q37452281 | ||
| Biological mechanisms of bevacizumab-associated adverse events | Q37546065 | ||
| Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination? | Q37613493 | ||
| Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anti-cancer therapy? | Q37617724 | ||
| Secreted CLIC3 drives cancer progression through its glutathione-dependent oxidoreductase activity. | Q37651981 | ||
| HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs) | Q37690722 | ||
| Stromal fibroblasts present in breast carcinomas promote tumor growth and angiogenesis through adrenomedullin secretion | Q37716611 | ||
| The dynamic roles of TGF-β in cancer | Q37801347 | ||
| Angiogenesis-related factors are molecular targets for diagnosis and treatment of patients with esophageal carcinoma | Q37832115 | ||
| The tumor microenvironment: a target for combination therapy of breast cancer | Q38067162 | ||
| 'Cancer associated fibroblasts'--more than meets the eye. | Q38114651 | ||
| Podoplanin expression in cancer-associated fibroblasts correlates with VEGF-C expression in cancer cells of invasive ductal breast carcinoma | Q38395964 | ||
| Transcriptional over-expression of chloride intracellular channels 3 and 4 in malignant pleural mesothelioma | Q38456660 | ||
| Luteolin suppresses angiogenesis and vasculogenic mimicry formation through inhibiting Notch1-VEGF signaling in gastric cancer | Q38698840 | ||
| Vascular mimicry formation is promoted by paracrine TGF-β and SDF1 of cancer-associated fibroblasts and inhibited by miR-101 in hepatocellular carcinoma. | Q38735975 | ||
| p53 functional deficiency in human colon cancer cells promotes fibroblast-mediated angiogenesis and tumor growth. | Q38752162 | ||
| Role of the tumor stroma in resistance to anti-angiogenic therapy. | Q38828196 | ||
| Tumor necrosis factor α induces myofibroblast differentiation in human tongue cancer and promotes invasiveness and angiogenesis via secretion of stromal cell-derived factor-1. | Q38828968 | ||
| Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression | Q38839374 | ||
| GPER in CAFs regulates hypoxia-driven breast cancer invasion in a CTGF-dependent manner | Q38913417 | ||
| Co-migration of colon cancer cells and CAFs induced by TGFβ₁ enhances liver metastasis | Q38923300 | ||
| Norcantharidin enhances TIMP‑2 anti‑vasculogenic mimicry activity for human gallbladder cancers through downregulating MMP‑2 and MT1‑MMP. | Q38939660 | ||
| Importance of the interaction between immune cells and tumor vasculature mediated by thalidomide in cancer treatment (Review). | Q38947481 | ||
| CLIC3 controls recycling of late endosomal MT1-MMP and dictates invasion and metastasis in breast cancer | Q38976198 | ||
| The role of endoglin in post-ischemic revascularization. | Q39036151 | ||
| CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment | Q39036931 | ||
| Tumor-associated fibroblast-conditioned medium promotes tumor cell proliferation and angiogenesis | Q39049745 | ||
| Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer | Q39195929 | ||
| Cancer-associated fibroblasts do not respond to combined irradiation and kinase inhibitor treatment | Q39227644 | ||
| Vinorelbine inhibits angiogenesis and 95D migration via reducing hypoxic fibroblast stromal cell-derived factor 1 secretion | Q39285839 | ||
| Cancer-associated fibroblasts induce matrix metalloproteinase-mediated cetuximab resistance in head and neck squamous cell carcinoma cells | Q39312271 | ||
| Elevated expression of angiomodulin (AGM/IGFBP-rP1) in tumor stroma and its roles in fibroblast activation | Q39399018 | ||
| Zinc finger E-box binding homeobox 1 promotes vasculogenic mimicry in colorectal cancer through induction of epithelial-to-mesenchymal transition | Q39418945 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | angiogenesis | Q539568 |
| neoplasm | Q1216998 | ||
| signaling pathway | Q28864300 | ||
| P304 | page(s) | 3055-3065 | |
| P577 | publication date | 2019-03-01 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Cancer-associated fibroblast regulation of tumor neo-angiogenesis as a therapeutic target in cancer | |
| P478 | volume | 17 |
| Q90705823 | Cancer-associated fibroblast stimulates cancer cell invasion in an interleukin-1 receptor (IL-1R)-dependent manner |
| Q96128259 | Design and validation of fibroblast activation protein alpha targeted imaging and therapeutic agents |
| Q92996743 | Endothelial-to-Mesenchymal Transition (EndoMT): Roles in Tumorigenesis, Metastatic Extravasation and Therapy Resistance |
| Q91994824 | Exosomal miRNAs in tumor microenvironment |
| Q98291421 | Resistance to Anti-angiogenic Therapies: A Mechanism Depending on the Time of Exposure to the Drugs |
| Q99591486 | The Role of Cancer-Associated Fibroblasts and Extracellular Vesicles in Tumorigenesis |
| Q91704928 | Tumor microenvironment complexity and therapeutic implications at a glance |
Search more.